Globus Medical (GMED) – Press Releases
-
Globus Medical Schedules First Quarter Earnings Release and Conference Call
-
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
-
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
-
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
-
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
-
Globus Medical Reports Third Quarter 2023 Results
-
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
-
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
-
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
-
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
-
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
-
Globus Medical Completes Merger with NuVasive
-
Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600
-
Globus Medical Reports Second Quarter 2023 Results
-
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
-
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
-
Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis
-
Globus Medical Reports First Quarter 2023 Results
-
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
-
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
-
NuVasive Shareholders Approve Merger Agreement with Globus Medical
-
Globus Medical Schedules First Quarter Earnings Release and Conference Call
-
Globus Medical Schedules First Quarter Earnings Release and Conference Call
-
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
-
Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
-
Minimally Invasive Surgery - This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain
-
Globus Medical Reports Fourth Quarter and Full Year 2022 Results
-
Globus Medical Reports Fourth Quarter and Full Year 2022 Results
-
Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care
-
Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
-
Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
-
Globus Medical Reports Third Quarter 2022 Results
-
Globus Medical Reports Third Quarter 2022 Results
-
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
-
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
-
Globus Medical Reports Second Quarter 2022 Results
-
Globus Medical Reports Second Quarter 2022 Results
-
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
-
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
-
Globus Medical Announces First Surgeries Using Excelsius3D™
-
Globus Medical Announces First Surgeries Using Excelsius3D™
-
Globus Medical Reports First Quarter 2022 Results
-
Globus Medical Reports First Quarter 2022 Results
-
Globus Medical Schedules First Quarter Earnings Release and Conference Call
-
Globus Medical Schedules First Quarter Earnings Release and Conference Call
-
Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results
-
Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results
-
Globus Medical Announces the Expansion of its Share Repurchase Program
-
Globus Medical Announces the Expansion of its Share Repurchase Program
-
Globus Medical Reports Fourth Quarter and Full Year 2021 Results
Back to GMED Stock Lookup
